BioMarin Pharmaceutical Inc. (BMRN) Revenue by Segment
BioMarin Pharmaceutical revenue by segment at a glance
In Q2 fiscal 2026 (the quarter ended June 30, 2026), BioMarin Pharmaceutical's largest product or service was Product, with $984.39 million or 99% of revenue, up 21.1% from a year earlier. Next: Royalty and Other (1%).
By region, United States brought in 48%, Europe brought in 28% and Rest of World brought in 14% of revenue in Q3 fiscal 2021.
From company filings, in USD; latest quarter ended June 30, 2026; quarterly data from Q3 fiscal 2017.
BioMarin Pharmaceutical Inc.
Revenue breakdown
Fiscal quarters, from company filings
BioMarin Pharmaceutical revenue by product or service, last 4 quarters
| Product or service | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Product | $984.4M | $760.1M | $760.8M | $813.0M | 99% |
| Royalty and Other | $5.3M | $6.1M | $15.3M | $12.4M | 1% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
BioMarin Pharmaceutical revenue by region, last 4 quarters
| Region | Q3 FY21 | Q2 FY21 | Q1 FY21 | Q3 FY20 | Share |
|---|---|---|---|---|---|
| United States | $196.2M | $204.2M | $208.2M | $252.9M | 48% |
| Europe | $115.5M | $172.7M | $161.8M | $121.2M | 28% |
| Rest of World | $58.0M | $82.5M | $56.3M | $58.6M | 14% |
| Latin America | $39.0M | $42.2M | $59.7M | $44.1M | 10% |
In USD, fiscal quarters as reported; share = part of Q3 FY21 revenue.
Questions and answers
Which product or service makes the most money for BioMarin Pharmaceutical?
Product: $984.39 million, or 99% of revenue, in Q2 fiscal 2026.
What are BioMarin Pharmaceutical's main products and services?
By revenue in Q2 fiscal 2026: Product (99%) and Royalty and Other (1%).
Where does BioMarin Pharmaceutical make its money?
By region in Q3 fiscal 2021: United States (48%), Europe (28%), Rest of World (14%) and Latin America (10%).
